COMMUNIQUÉS West-GlobeNewswire

Innovate GBM Rings the NASDAQ Closing Bell in Honor of Brain Tumor Patients and Community
24/06/2025
LOS ANGELES, June 24, 2025 (GLOBE NEWSWIRE) -- Innovate GBM, a 501(c)(3) nonprofit organization dedicated to transforming the future of brain tumor research and treatment through collaboration, infrastructure, and [...]
SeaStar Medical Announces Two Feature Stories on QUELIMMUNE Adoption and Patient Testimonial of Life-Saving Therapy
24/06/2025
Cincinnati Children’s Hospital Medical Center Discusses QUELIMMUNE Therapy Adoption A Father and Patient Describe Their Real-Life Experience with the QUELIMMUNE Therapy DENVER, June 24, 2025 (GLOBE NEWSWIRE) -- SeaStar [...]
Candel Therapeutics Announces $15 million Registered Direct Offering of Common Stock
24/06/2025
NEEDHAM, Mass., June 24, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies [...]
Progyny Adds Pelvic Floor Therapy, Continuing to Close Gaps in Care Across Women’s Health
24/06/2025
With nearly one third of women impacted by pelvic floor disorders, expanded care access and education from Progyny will help eliminate the silent suffering NEW YORK, June 24, 2025 (GLOBE NEWSWIRE) -- Progyny , Inc. ( [...]
Actuate Therapeutics Highlights Significant and Sustained Survival Benefit in Key Metastatic Pancreatic Cancer Patient Populations in Phase 2 Elraglusib Trial
24/06/2025
- Near doubling of 1-year overall survival (OS), increased median OS of 4 months (12.5 vs 8.5 months), and 43% reduction in risk of death in patients treated with at least one cycle (4 weeks) of elraglusib plus [...]
Olympia Pharmaceuticals Launches OlympiaYou.com: Empowering Patients Through Innovative Wellness and Sexual Health Support
24/06/2025
New platform brings erectile dysfunction, weight loss, and wellness support directly to individuals through virtual pharmacist care and nationwide delivery ORLANDO, Fla., June 24, 2025 (GLOBE NEWSWIRE) -- Olympia [...]
Rebirth Globe Launches Global Expansion Across the Americas and Middle East, Welcomes International Medical Expert Miss Lucy Yang
24/06/2025
Global expansion into the Americas and Middle East fuels Rebirth Globe’s $15M growth projection for 2025 Rebirth Logo NEW YORK, June 24, 2025 (GLOBE NEWSWIRE) -- Rebirth Globe, a pioneering leader in advanced aesthetic [...]
Peter Gilgan investing $60 million to build extraordinary at St. Joseph's Health Centre
24/06/2025
Building Home of Extraordinary: Gilgan provides historic gift for state-of-the-art patient tower PETER GILGAN GIVES DEEPLY PERSONAL GIFT TO ST. JOE’S TORONTO, June 24, 2025 (GLOBE NEWSWIRE) -- Peter Gilgan, founder and [...]
Smith+Nephew’s new TRIGEN™ MAX Tibia Nailing System brings ‘next-level nailing’ to trauma surgeons repairing tibial fractures
24/06/2025
The future of fracture fixation with novel side-specific nails featuring variable angle locking technology Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the launch of its new [...]
Bioma Probiotics Launches to Address Weight Loss through Microbiome and Digestive Balance
24/06/2025
Explore the science behind Bioma probiotics and their impact on gut health, metabolism, and weight loss management. Understand how your digestive system influences weight regulation and energy levels, and discover user [...]
BioAdaptives Announces National Launch of Pawpa™ Regen
24/06/2025
Revolutionary Canine Supplement Promotes Regenerative Healing Through Stem Cell Activation LAS VEGAS , June 24, 2025 (GLOBE NEWSWIRE) -- via IBN -- BioAdaptives, Inc. (OTC Pink: BDPT), an innovator in nutraceutical and [...]
Fortrea et Emery Pharma annoncent une collaboration stratégique visant à mener des études sur les interactions médicamenteuses répondant aux normes de la FDA en utilisant la rifampicine
24/06/2025
Cette collaboration permet la réalisation de tests de détection des impuretés de nitrosamine offrant aux promoteurs la possibilité de démontrer l’utilisation acceptable de la rifampicine dans les études sur les [...]
Cosmos Health Enters U.S. Market with Strategic Made-in-America Manufacturing, Mitigating Tariff Risks; Executes Agreement with New Jersey-Based DolCas Biotech
24/06/2025
CHICAGO, June 24, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company'') (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of [...]
Le Dr Mark Kirchhof nommé président de l’Association canadienne de dermatologie
24/06/2025
OTTAWA, 24 juin 2025 (GLOBE NEWSWIRE) -- L’Association canadienne de dermatologie (ACD) est fière d’annoncer la nomination du Dr Mark Kirchhof au poste de président de l’ACD. Il assumera ses fonctions à compter du 19 [...]
Dr. Mark Kirchhof appointed President of the Canadian Dermatology Association
24/06/2025
OTTAWA, June 24, 2025 (GLOBE NEWSWIRE) -- The Canadian Dermatology Association (CDA) is pleased to announce the appointment of Dr. Mark Kirchhof as CDA President, effective June 19, 2025. Dr. Mark Kirchhof is a [...]
Longeveron® Announces Completion of Enrollment of Pivotal Phase 2b Clinical Trial Evaluating Laromestrocel as a Treatment for Hypoplastic Left Heart Syndrome (HLHS)
24/06/2025
Top-line trial results are anticipated in the third quarter of 2026, after the final follow-up at 12-months Laromestrocel Biological License Application (BLA) submission for full traditional approval for HLHS [...]
Amarin Announces Exclusive License and Supply Agreement with Recordati to Commercialize VAZKEPA® (Icosapent Ethyl) in Europe
24/06/2025
-- Company to Streamline Global Operations, Resulting in Approximately $70 Million of Cost Savings Over Next 12 Months and Accelerated Path to Positive Cash Flow -- -- Conference Call Today at 8:00 a.m. EDT with [...]
Iridex Announces First Patient Enrolled in an Independent Landmark Investigator-Led UK Study Evaluating MicroPulse® Technology as an Adjunct to anti-VEGF Therapy for Diabetic Macular Edema
24/06/2025
MOUNTAIN VIEW, Calif., June 24, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the [...]
Revolution Medicines Enters Into $2 Billion Flexible Funding Agreement with Royalty Pharma to Support Global Development and Commercialization of RAS(ON) Inhibitor Portfolio for Patients with RAS-Addicted Cancers
24/06/2025
Flexible funding provides $2 billion in committed capital comprised of up to $1.25 billion of synthetic royalty and up to $750 million in corporate debt Company moving forward with independent global commercialization [...]

Pages